biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by Sinbobon Mar 18, 2013 1:23pm

197 Views

Post# 21146102

Trading ....

Stock is jumpy so far trading 94,000 shares so far ( average is 53,000/day) with a low of $1.39 and now asking $1.50. Chart is still day to day.

Are there any trading antics? Who knows but if you read that news you will get a good idea of how it can be done. That still leaves the big boys HFT, shorting and much more. Solid good news trumps all. All the banks are involved.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario